晚期乳腺癌的临床试验
总计39634个结果
-
Institut Paoli-CalmettesNovartis Pharmaceuticals招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Sun Yat-sen UniversityChengdu Biostar Pharmaceuticals尚未招聘
-
R-PharmGlaxoSmithKline终止
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de Medicina终止Locally Advanced HER2-negative Breast Cancer巴西
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de Medicina终止Locally Advanced HER2-positive Breast Cancer巴西
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital招聘中
-
Allegheny Singer Research Institute (also known...招聘中
-
Mayo ClinicNational Cancer Institute (NCI)暂停
-
Sidney Kimmel Comprehensive Cancer Center at Johns...完全的I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性乳腺癌 | 导管原位癌美国
-
Ohio State University Comprehensive Cancer Center尚未招聘
-
Carrick Therapeutics LimitedPfizer招聘中
-
SCRI Development Innovations, LLCDaiichi Sankyo, Inc.招聘中
-
Consorzio Oncotech招聘中
-
Rhizen Pharmaceuticals SA完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangzhou Anjie Biomedical Technology Co., Ltd.完全的
-
Heidelberg UniversityDafra Pharma; Hector-Stiftung; Monika-Kutzner Stiftung, Berlin, Germany; HEIFAN-Heidelberger Förderverein...完全的
-
MacroGenics终止黑色素瘤 | 非小细胞肺癌 | 头颈部鳞状细胞癌 | 三阴性乳腺癌 | 转移性去势抵抗性前列腺癌 | 晚期实体瘤,成人西班牙, 美国, 澳大利亚, 波兰
-
Advocate Health Care完全的
-
Novartis Pharmaceuticals主动,不招人晚期 HER2+ 乳腺癌比利时, 法国, 中国, 意大利, 西班牙, 马来西亚, 美国, 火鸡
-
Sunnybrook Health Sciences Centre完全的
-
Pfizer不再可用
-
National Institute of CancerologíaNational Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.终止
-
Arcus Biosciences, Inc.招聘中宫颈癌 | 胃癌 | 食道癌 | 卵巢癌 | 膀胱癌 | 晚期癌症 | 非小细胞肺癌 (NSCLC) | 晚期恶性肿瘤 | 肾细胞癌 (RCC) | 三阴性乳腺癌 (TNBC) | 头颈部鳞状细胞癌 (HNSCC) | 胃食管结合部癌 (GEJ)美国, 澳大利亚
-
Memorial Sloan Kettering Cancer Center招聘中
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany撤销乳腺癌 | 晚期实体瘤
-
Jaroslaw HepelBrown University; Rhode Island Hospital; Women and Infants Hospital of Rhode Island撤销乳腺癌 | 浸润性乳腺癌 | 导管原位癌
-
National Cancer Institute (NCI)主动,不招人浸润性乳腺癌 | 三阴性乳腺癌 | I 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | 0 期乳腺癌 AJCC v6 和 v7美国, 加拿大, 波多黎各
-
Danish Breast Cancer Cooperative GroupDanish Cancer Society主动,不招人
-
National Cancer Institute (NCI)GlaxoSmithKline完全的IV 期乳腺癌 | 复发性乳腺癌 | 浸润性乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌美国
-
Washington University School of MedicineAclaris Therapeutics, Inc.撤销
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La Roche招聘中
-
Mayo ClinicNational Cancer Institute (NCI)招聘中
-
Medical University of South Carolina终止
-
Guangdong Provincial People's HospitalSun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Shantou Central Hospital招聘中
-
Carrick Therapeutics LimitedBerlin-Chemie AG Menarini Group招聘中乳腺癌 | 转移性乳腺癌 | 局部晚期乳腺癌美国, 西班牙, 法国, 英国
-
Hoffmann-La Roche主动,不招人